• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健的社会评价与健康状况的个人评价。基于挪威和澳大利亚调查的四种健康状况量表工具有效性的证据。

Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys.

作者信息

Nord E, Richardson J, Macarounas-Kirchmann K

机构信息

Norwegian National Institute of Public Health.

出版信息

Int J Technol Assess Health Care. 1993 Fall;9(4):463-78. doi: 10.1017/s0266462300005390.

DOI:10.1017/s0266462300005390
PMID:8288424
Abstract

In most of the cost-utility literature, quality-adjusted life-year (QALY) gains are interpreted as a measure of social value. Given this interpretation, the validity of different multi-attribute health-state scaling instruments may be tested by comparing the values they provide on the 0-1 QALY scale with directly elicited preferences for person trade-offs between different treatments (equivalence of numbers of different patients treated). Norwegian and Australian public preferences as measured by the person trade-off suggest that the EuroQol Instrument assigns excessively low values to health states. This seems to be even more true of the McMaster Health Classification System. The Quality of Well-being Scale appears to compress states toward the middle of the 0-1 scale. By contrast, the Rosser/Kind index fits reasonably well with directly measured person trade-off data.

摘要

在大多数成本效用文献中,质量调整生命年(QALY)的增加被视为社会价值的一种衡量标准。基于这种解释,可以通过比较不同多属性健康状态量表在0至1 QALY量表上提供的值与直接引出的不同治疗之间个人权衡偏好(不同治疗患者数量的等效性),来检验不同多属性健康状态量表的有效性。通过个人权衡测量的挪威和澳大利亚公众偏好表明,欧洲五维度健康量表(EuroQol)对健康状态赋予的值过低。麦克马斯特健康分类系统似乎更是如此。幸福感量表似乎将状态压缩到0至1量表的中间。相比之下,罗瑟/金氏指数(Rosser/Kind index)与直接测量的个人权衡数据相当吻合。

相似文献

1
Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys.医疗保健的社会评价与健康状况的个人评价。基于挪威和澳大利亚调查的四种健康状况量表工具有效性的证据。
Int J Technol Assess Health Care. 1993 Fall;9(4):463-78. doi: 10.1017/s0266462300005390.
2
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
3
Preferences for health outcomes and cost-utility analysis.对健康结果的偏好与成本效用分析。
Am J Manag Care. 1997 May;3 Suppl:S8-20.
4
EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.欧洲五维度健康量表:与健康相关的生活质量测量。挪威普通公众对健康状态的估值。
Health Policy. 1991 Jun;18(1):25-36. doi: 10.1016/0168-8510(91)90141-j.
5
The validity of using health state indexes in measuring the consequences of traffic injury for public health.
Soc Sci Med. 1995 May;40(10):1385-98. doi: 10.1016/0277-9536(94)00264-t.
6
Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project.80岁及以上住院患者的健康价值观。HELP研究人员。住院老年人纵向项目。
JAMA. 1998 Feb 4;279(5):371-5. doi: 10.1001/jama.279.5.371.
7
The trade-off between severity of illness and treatment effect in cost-value analysis of health care.医疗保健成本效益分析中疾病严重程度与治疗效果之间的权衡。
Health Policy. 1993 Aug;24(3):227-38. doi: 10.1016/0168-8510(93)90042-n.
8
The validity of a visual analogue scale in determining social utility weights for health states.视觉模拟量表在确定健康状态的社会效用权重方面的有效性。
Int J Health Plann Manage. 1991 Jul-Sep;6(3):234-42. doi: 10.1002/hpm.4740060308.
9
Quality-adjusted life years, utility theory, and healthy-years equivalents.质量调整生命年、效用理论与健康年当量。
Med Decis Making. 1989 Apr-Jun;9(2):142-9. doi: 10.1177/0272989X8900900209.
10
Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?使用时间权衡法和离散选择实验法评估健康:维度顺序会影响健康状态值吗?
Value Health. 2016 Mar-Apr;19(2):210-7. doi: 10.1016/j.jval.2015.11.005. Epub 2016 Jan 8.

引用本文的文献

1
Disability Weights for Osteoporosis and Osteoporotic Fractures in South Korea.韩国骨质疏松症及骨质疏松性骨折的失能权重
J Bone Metab. 2019 May;26(2):83-88. doi: 10.11005/jbm.2019.26.2.83. Epub 2019 May 31.
2
What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews.有哪些证据可以证明通用偏好为基础的衡量标准的表现?系统综述的综述。
Eur J Health Econ. 2018 May;19(4):557-570. doi: 10.1007/s10198-017-0902-x. Epub 2017 May 30.
3
Cost-value analysis of health interventions: introduction and update on methods and preference data.
卫生干预措施的成本-价值分析:方法与偏好数据的介绍及更新
Pharmacoeconomics. 2015 Feb;33(2):89-95. doi: 10.1007/s40273-014-0212-4.
4
Transforming EQ-5D utilities for use in cost–value analysis of health programs.将 EQ-5D 效用值转化用于卫生计划的成本-效益分析。
Eur J Health Econ. 2015 Apr;16(3):313-28. doi: 10.1007/s10198-014-0576-6.
5
Theory of constraints for publicly funded health systems.公共资助卫生系统的约束理论。
Health Care Manag Sci. 2013 Mar;16(1):62-74. doi: 10.1007/s10729-012-9208-9. Epub 2012 Aug 21.
6
Severity as an independent determinant of the social value of a health service.严重程度是卫生服务社会价值的一个独立决定因素。
Eur J Health Econ. 2011 Apr;12(2):163-74. doi: 10.1007/s10198-010-0249-z. Epub 2010 May 9.
7
Trading people versus trading time: what is the difference?交易人还是交易时间:有何不同?
Popul Health Metr. 2005 Nov 10;3:10. doi: 10.1186/1478-7954-3-10.
8
Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.HIV/AIDS患者中15D、EQ-5D和SF-6D基于偏好的效用比较。
Qual Life Res. 2005 May;14(4):971-80. doi: 10.1007/s11136-004-3211-7.
9
Willingness to pay for a QALY: theoretical and methodological issues.支付意愿以获取一个质量调整生命年:理论与方法学问题。
Pharmacoeconomics. 2005;23(5):423-32. doi: 10.2165/00019053-200523050-00002.
10
How do Zimbabweans value health states?津巴布韦人如何看待健康状况?
Popul Health Metr. 2003 Dec 16;1(1):11. doi: 10.1186/1478-7954-1-11.